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doi:10.1Objective: The ability to predict intensive care unit length of stay greatly facilitates triage and resource alloca-
tion for postoperative cardiac surgical patients in the intensive care unit. We developed a simple, intuitive Sur-
gical Procedure Assessment score that integrates surgical complexity (1, low; 2, intermediate; 3, high) with
patient comorbidity (A, minimal; B, substantial).We hypothesized that the Surgical Procedure Assessment score
would predict intensive care unit length of stay, discriminate preoperatively between fast-track and prolonged-
stay patients, and compare favorably with more complex risk scores.
Methods:After institutional review board approval, 1201 cardiac surgical patients were preoperatively assigned
a Surgical Procedure Assessment score, as well as a Parsonnet, Tuman, Tu, and Cardiac Anesthesia Risk Eval-
uation score. We compared these scores with regard to prediction of intensive care unit length of stay, as well as
their concordance in predicting intensive care unit length of stay of less than 48 hours (fast track) andmore than 7
days (prolonged stay).
Results: Intensive care unit length of stay increased significantly with increasing Surgical Procedure Assess-
ment scores (P<.01, Cuzick’s test for trend). The lowest Surgical Procedure Assessment score (1A) predicted
intensive care unit length of stay of less than 48 hours, and the higher Surgical Procedure Assessment scores (2B
or 3) predicted intensive care unit length of stay of more than 7 days more accurately than the Parsonnet, Tuman,
Tu and Cardiac Anesthesia Risk Evaluation scores.
Conclusions: The Surgical Procedure Assessment score predicts intensive care unit length of stay better than
other comparable scores. It is simple, intuitive, and easily understood by all caregivers and can preoperatively
discriminate fast-track from prolonged-stay patients. It is a useful tool to facilitate intensive care unit triage.
(J Thorac Cardiovasc Surg 2011;142:443-50)The lack of readily available postoperative intensive care
unit (ICU) beds is an important rate-limiting step in cardiac
surgical throughput. This problem has been addressed to
some extent by the development of fast-track protocols
that minimize ICU time or even allow the ICU to be by-
passed altogether. However, this recourse is attenuated by
the national trend toward increasingly complex procedures
in patients of increasingly advanced age.1 Patients with ex-
tended ICU length of stay (LOS) provide an enormous re-
source burden. We have previously observed that although
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Mfor more than 14 days, they account for 30% of the ICU pa-
tient days.2 Reliable preoperative prediction of postopera-
tive ICU LOS could facilitate rational bed allocation and
maximize use of the scarce resource that ICU beds repre-
sent. However, most scoring systems in present use are
complex and were developed to allow cardiac surgeons
and cardiologists to anticipate operative mortality and risk
rather than ICU LOS and potential ICU resource use.3,4
We considered that it would be helpful to have an intuitive
and simple algorithm that is easily understood by all parties
involved in ICU planning: surgical case schedulers, nurses,
hospital administrators, surgeons, and anesthesiologists.
We therefore devised a Surgical Procedure Assessment
(SPA) score based on just 2 variables: the complexity of
the surgical procedure (1, low; 2, medium; or 3, high) and
known patient comorbidity. Thus patients undergoing less
complex operations (eg, coronary artery bypass grafting
and single-valve operations) are assigned an SPA score of
1, those undergoing more complex operations (eg, redo,
coronary artery bypass grafting valve, and multiple-valve
operations or cardiac surgery in combination with the
maze procedure or heart transplantation) are assigned an
SPA score of 2, and those undergoing the most complex
operations (eg, ventricular assist device placement andrdiovascular Surgery c Volume 142, Number 2 443
TABLE 1. Classification of the Surgical Procedure Assessment score
SPA
score Surgical factors Patient factors
1A Low complexity (eg, CABG, AVR,
MVR)
No comorbidity
IB þComorbidity
2A Moderate complexity (eg, CABG
and valve, multiple valves,
reoperation, cardiac surgeryþmaze
procedure, heart transplantation)
No comorbidity
2B þComorbidity
3 High complexity (eg, ventricular
assist device, lung transplantation)
 Comorbidity
Comorbidity:
 Congestive heart failure requiring inotropic support
B Milrinone, dobutamine, nesiritide, or intra-aortic balloon pump
 LV ejection fraction<20%
 Arrhythmias: ventricular tachycardia
Abbreviations and Acronyms
CARE ¼ Cardiac Anesthesia Risk Evaluation
ICU ¼ intensive care unit
LOS ¼ length of stay
SPA ¼ Surgical Procedure Assessment
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Mlung transplantation) are assigned an SPA score of 3. Ab-
sence of comorbidity is designated by the suffix A, and sub-
stantial comorbidity (eg, organ system failure, arrhythmias,
or insulin-dependent diabetes) is designated with the suffix
B (Table 1). We hypothesized that the SPA score could pre-
operatively discriminate between fast-track (ICU LOS<48
hours) and prolonged-stay (ICU LOS >7 days) patients
and perform as well or better than 4 other validated scoring
systems: the Parsonnet,5 Tuman,6 Tu,7 andCardiacAnesthe-
sia Risk Evaluation (CARE)8 scores.  Liver disease
B Increased bilirubin level or coagulation parameters
 Insulin-dependent diabetes
 End-stage renal failure
 Symptomatic COPD
B Home oxygen
 Severe systemic disease (eg, systemic lupus, rheumatoid arthritis,
sickle cell disease)
SPA, Surgical Procedure Assessment; CABG, coronary artery bypass grafting; AVR,
aortic valve replacement or repair; MVR, mitral valve replacement or repair; LV,
left ventricular; COPD, chronic obstructive pulmonary disease.MATERIALS AND METHODS
From January 1 to December 31, 2002, all adult patients undergoing car-
diac surgery at Columbia University Medical Center were enrolled in the
study. The Institutional Review Board of Columbia University waived
the requirement to obtain informed consent.
SPA, Parsonnet, Tuman, Tu, and CARE scores were assigned before the
operation. Baseline demographics, ICU LOS, hospital LOS, and in-
hospital mortality were prospectively collected on all patients. The hospital
charges were retrieved from the hospital billing system. Patients were des-
ignated into groups based on their ICU LOS: fast track, less than 48 hours;
prolonged stay, more than 7 days.
We applied Cuzick’s nonparametric test for trend, an extension of the
Wilcoxon rank test,9 to evaluatewhether therewas a statistically significant
progression of ICU LOS as the SPA score assignment increased from 1A
through 3.
We compared the SPA score with the Parsonnet, Tuman, Tu, and CARE
scores by developing multiple regression models that estimated the ability
of each score to explain the observed variability of ICU and hospital LOS,
in-hospital mortality, and hospital charges. The LOS data and hospital
charges underwent logarithmic transformation to achieve a normal distri-
bution before being entered into linear regression models. Logistic regres-
sion was used to test the association between SPA scores and 4 other
validated scoring systems and in-hospital mortality. The Hosmer and Le-
meshow goodness-of-fit test was applied to test model fitness with logistic
regressions on in-hospital mortality. Receiver operating characteristic
curves were also used to investigate the area under the curve with SPA
scores and 4 other scoring systems on in-hospital mortality. Cuzick’s non-
parametric test for trend, an extension of the Wilcoxon rank test, was used
to evaluate whether there was a statistically significant progression of ICU
LOS, hospital LOS, in-hospital mortality, and hospital charges as the SPA
score assignment increased from 1A through 3.
We tested the ability of all 5 scoring systems to predict fast-track and
prolonged-stay patients. Relative risks, odds ratios, sensitivities, specific-
ities, positive and negative predictive values, and likelihood ratios were
used to evaluate the concordance of the lowest SPA score (1A) with ICU
LOS of less than 48 hours in comparison with the lowest Parsonnet (<5),
Tuman (<2), Tu (<2), and CARE (1) scores, respectively. We further tested
these measures against an even shorter ICU LOS (<24 hours).
The same tests were used to evaluate the concordance of the highest SPA
scores (2B and 3) with ICU LOS of more than 7 days in comparison with
the highest Parsonnet (>15), Tuman (>6), Tu (>6), and CARE (4, 5, or 5E)444 The Journal of Thoracic and Cardiovascular Surgscores, respectively. We further tested these measures against an even lon-
ger ICU LOS (>10 days).
Values are presented as means  standard deviations. Comparisons be-
tween groups were made by using the unpaired t test for values with Gauss-
ian distribution and by using the Mann–Whitney (Wilcoxon rank) test or
Spearman test for correlation for continuous variables without normal
distribution. Gaussian distribution was determined by using the Kolmo-
gorov–Smirnov test. The c2 test or 1-way analysis of variance was used
as appropriate. P values were 2-tailed.
SAS 9.1 software (SAS, Inc, Cary, NC) was used for the regression
models, and SPSS 11.0.4 (SPSS, Inc, Chicago, Ill) and GraphPad Prism
4.0 (GraphPad, Inc, San Diego, Calif) software were used for remainder
of the statistical analysis.
RESULTS
Patients’ Characteristics
All 1201 adult patients undergoing cardiac surgery from
January 1, 2002, to December 31, 2002, at Columbia Univer-
sity Medical Center were included. One thousand one
hundred two (91.2%) patients were admitted to the cardio-
thoracic intensive care unit, and 99 patients (8.8%) were ad-
mitted to the surgical intensive care unit of Columbia
UniversityMedical Center. Patients’ demographics and types
of cardiac surgical procedures are listed in Table 2. The entire
group of 1201 cardiac surgical patients used 4065 ICU bed
days, with a mean ICU LOS of 3.38 days. Of these, only
106 (8.8%) had a prolonged stay (ICU LOS>7 days), but
these patients used 45.6% of all ICU bed days.ery c August 2011
TABLE 2. Patients’ characteristics
SPA 1A
393 (32.7%)
SPA 1B
165 (13.7%)
SPA 2A
303 (25.2%)
SPA 2B
307 (25.6%)
SPA 3
33 (2.8%)
P value
(ANOVA)
Preoperative
Female sex, n (%) 104 (26.5) 70 (42.4) 104 (34.3) 123 (40.1) 9 (27.3) .0035
Age (y), mean  SD 64.2  13.0 66.5  12.4 63.7  15.4 63.8  14.7 50.3  15.9 <.0001
BMI (kg/m2), mean  SD 29.6  16.9 28.9  14.6 29.2  20.0 30.7  30.1 27.5  6.2 .0122
End-stage renal failure,
n (%)
0 11 (6.7) 0 9 (2.9) 4 (12.1) .004
Diabetes, n (%) 90 (22.9) 57 (34.5) 57 (18.8) 85 (27.7) 8 (24.2) NS
IDDM, n (%) 0 27 (16.4) 0 27 (8.8) 2 (6.1) NS
NIDDM, n (%) 90 (22.9) 30 (18.2) 57 (18.8) 58 (18.9) 6 (18.2) NS
Ejection fraction,
mean  SD
51.7  11.4 46.8  14.4 51.5  12.1 41.2  17.5 21.2  11.4 <.0001
Operations
CABG, n (%) 279 (71.0) 88 (53.3) 104 (34.3)* 55 (17.9)* 0
OPCABG, n (%) 91 (23.2) 20 (12.1) 19 (6.3)* 13 (4.2)* 0
Single AVR, n (%) 68 (17.3) 28 (17.0) 28 (9.2)* 24 (7.8)* 0
Single MVR, n (%) 42 (10.7) 43 (26.1) 15 (5.0)* 18 (5.9)* 0
Other single valves, n (%) 1 (0.3) 4 (2.4) 0 2 (0.7) 0
Multiple valves , n (%) 0 0 12 (4.0) 48 (15.6) 0
CABG and valve, n (%) 0 0 81 (26.7) 71 (23.1) 0
VAD, n (%) 0 0 0 0 33 (100)
Heart transplantation,
n (%)
0 0 3 (1.0) 68 (22.1) 0
Reoperation, n (%) 0 0 76 (25.1) 85 (27.7) 12 (36.4) <.0001
Other, n (%) 3 (0.8) 2 (1.2) 60 (19.8) 21 (6.8) 0 <.0001
Intraoperative
CPB time (h:min),
mean  SD
1:18  0:51 1:38  0:53 2:26  5:48 2:19  1:08 1:56  1:05 <0.0001
AXC time (h:min),
mean  SD
0:51  0:36 1:05  0:37 1:14  0:47 1:32  0:47 0:29  0:33 <.0001
Postoperative
ICU LOS (d), mean  SD 1.6  1.5 2.3  2.5 3.1  5.4 5.4  7.8 13.8  12.9 <.0001
Hospital LOS (d),
mean  SD
6.7  5.6 7.8  4.6 9.2  10.0 16.1  19.7 46.0  36.1 <.0001
Charges/US dollars,
mean  SD
56,693  37,912 68,997  42,474 88,971  102,127 200,083  251,684 510,068  286,866 <.0001
ICU mortality, n (%) 1 (0.3) 3 (1.8) 10 (3.3) 19 (6.2) 6 (18.2) <.0001
Hospital mortality, n (%) 1 (0.3) 4 (2.4) 10 (3.3) 26 (8.5) 9 (27.3) <.0001
Scores
Parsonnet, mean  SD 9.9  7.7 16.3  9.5 15.0  10.4 21.6  12.6 23.7  15.0 <.0001
CARE score, mean  SD 1.8  0.6 2.4  0.7 3.2  1.1 4.1  1.0 4.4  1.1 <.0001
Tuman score, mean  SD 2.2  1.8 3.5  1.9 4.2  2.6 5.3  2.7 5.7  2.9 <.0001
Tu score, mean  SD 2.7  1.7 3.7  1.8 4.1  2.6 5.0  2.4 4.8  2.8 <.0001
SPA, Surgical Procedure Assessment; ANOVA, analysis of variance; SD, standard deviation; BMI, body mass index; NS, not significant (P>.05); IDDM, insulin-dependent di-
abetes mellitus; NIDDM, non–insulin-dependent diabetes mellitus; CABG, coronary artery bypass grafting; OPCABG, off-pump coronary artery bypass grafting; AVR, aortic
valve replacement or repair;MVR, mitral valve replacement or repair; VAD, ventricular assist device; CPB, cardiopulmonary bypass; AXC, aortic crossclamp time; ICU, intensive
care unit; LOS, length of stay; CARE, Cardiac Anesthesia Risk Evaluation. *With other operations, such as the maze procedure.
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MSPA Score and ICU LOS
The distribution of SPA scores and sex, age, and selected
comorbidities is shown in Table 2. The proportion of pa-
tients assigned SPA scores of 1A, 1B, 2A, 2B, and 3 was
32.7%, 13.7%, 25.2%, 25.6%, and 2.7%, respectively.
There were significantly fewer female patients who had
scores of SPA 1A or 3. Patients with scores of SPA 3The Journal of Thoracic and Cawere significantly younger than those in the other SPA
groups, had significantly lower preoperative left ventricular
ejection fraction, and also had a significantly higher inci-
dence of end-stage renal disease (12.1%) compared with
patients with SPA scores of 1B (2.9%) and 2B (6.7%).
There was no difference in the incidence of preexisting di-
abetes between the groups.rdiovascular Surgery c Volume 142, Number 2 445
FIGURE 1. Intensive care unit length of stay after cardiac surgery comparing the Surgical Procedure Assessment (SPA) score with the Parsonnet, Cardiac
Anesthesia Risk Evaluation (CARE), Tuman, and Tu scores (means  standard deviations).
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MThere was an exponential and statistically significant in-
crease in ICU LOS with increasing SPA scores (Figure 1, A).
The mean ICU LOS between SPA scores 1A, 1B, 2A,
2B, and 3 increased from 1.6 1.5 days to 2.3  2.5,
3.1  5.4, 5.4  7.8, and 13.8  12.9 days, respectively
(P< .01, Cuzick’s nonparametric test for trend). Compa-
rable graphs for the Parsonnet, Tuman, Tu, and CARE
scores are shown in Figure 1, B to E. Hospital LOS, mor-
tality, and charges also increased significantly with each
incremental increase in SPA score (Figure 2).
Prediction of ICU LOS
We developed regression models to assess the ability of
the SPA score to explain the variability of ICU and hos-
pital LOS, mortality, and hospital charges compared446 The Journal of Thoracic and Cardiovascular Surgwith the Parsonnet, Tuman, Tu, or CARE scores. After
log transformation of LOS and charges to achieve
a Gaussian distribution, ICU and hospital LOS and
charges were modeled with linear regression by using
a stepwise procedure with backward elimination. A logis-
tic regression model was used to assess the ability of the
scores to explain the variability of mortality. All logistic
models fit the data well with the Hosmer and Lemeshow
goodness-of-fit test. Receiver operating characteristic
curve analyses suggested that the SPA score provides
the largest area under the curve (ie, 0.781), whereas the
4 other scoring systems have areas under the curve rang-
ing from 0.725 to 0.774 (Table 3). The SPA score per-
formed best at explaining the variability of ICU LOS,
mortality, and hospital charges, and the CARE scoreery c August 2011
FIGURE 2. The Surgical Procedure Assessment (SPA) score and length of hospital stay (A), mortality (B), and hospital charges (C, in US dollars [USD];
means  standard deviations).
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Mperformed best at explaining the variability in hospital
LOS (Table 4).
Identification of Fast-Track Patients
Of the 393 patients with an SPA score of 1A, 306
(77.9%) had an ICU LOS of less than 48 hours, and
182 (46.3%) had an ICU LOS of less than 24 hours. In
contrast, 393 (49%) of 808 patients with an SPA score
of greater than 1A had an ICU LOS of more than 48The Journal of Thoracic and Cahours, and 184 (22.8%) had an ICU LOS less than 24
hours.
An SPA score of 1Awas better able to predict a short ICU
stay, whether less than 48 hours or less than 24 hours, than
a Parsonnet score of less than 5, a Tuman score of less than
2, a Tu score of less than 2, or a CARE score of 1. The sen-
sitivities, specificities, relative risks, odds ratios, positive
and negative predictive values, and likelihood ratios are de-
picted in Table 5.rdiovascular Surgery c Volume 142, Number 2 447
TABLE 3. Logistic regression model of in-hospital mortality for
scoring system comparison
Scoring
system
ROC
curve AUC
Logistic regression model
Coefficient P value
Wald
c2 test
P value,
HL test
SPA 0.781 1.061 <.0001 38.9 0.32
Parsonnet 0.725 0.074 <.0001 45.9 0.46
CARE 0.766 0.768 <.0001 27.4 0.19
Tuman 0.746 0.317 <.0001 37.8 0.20
Tu 0.744 -0.464 .08 3.0 0.79
ROC curve AUC, Area under the curve of the receiver operator curve of the scoring
system to predict in-hospital mortality;HL test, Hosmer and Lemeshow goodness-of-
fit test (P<.05 rejects H0 that the model fits the data well); SPA, Surgical Procedure
Assessment; CARE, Cardiac Anesthesia Risk Evaluation.
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MIdentification of Prolonged-Stay Patients
Of the 340 patients with an SPA score of 2B or 3, 273
(80.3%) had an ICU LOS of more than 7 days, and 181
(53.2%) had an ICU LOS of more than 10 days. In contrast,
366 (42.5%) of 861 patients with an SPA score of greater
than 2B had an ICU LOS of more than 7 days, and 148
(17.2%) had an ICU LOS of more than 10 days.
An SPA score of 2A or 3 was better able to predict pro-
longed ICU stay, whether more than 7 days or more than
10 days, than a Parsonnet score of greater than 15, a Tuman
score of greater than 6, a Tu score of greater than 6, or
a CARE score of 4, 5, or 5E. The sensitivities, specificities,
relative risks, odds ratios, positive and negative predictive
values, and likelihood ratios are depicted in Table 6.DISCUSSION
We have demonstrated that the SPA score, a simple, intu-
itive preoperative assignment of risk, can predict ICU LOS
after cardiac surgery. It does so as well or better than the
Parsonnet, Tuman, Tu, or CARE scores. Moreover, it is bet-
ter able to discriminate between fast-track (ICU LOS<48
hours) and prolonged-stay (>7 days) patients. The SPA
score also correlates with hospital LOS, charges, and in-
hospital mortality.
The ability to preoperatively predict short versus pro-
longed LOS greatly facilitates ICU throughput and alloca-
tion of ICU resources and improves the efficiency of
a cardiac surgical service. Today, the lack of availableTABLE 4. Linear regression models of ICU LOS, hospital LOS, and hosp
Scoring system
ICU LOS
Coefficient P value R2 Coefficien
SPA 0.321 <.0001 0.188 0.292
Parsonnet 0.028 <.0001 0.112 0.022
CARE 0.273 <.0001 0.156 0.285
Tuman 0.133 <.0001 0.142 0.106
Tu 0.015 .4 0.055 0.001
LOS and charges were log-transformed before modeling. ICU, Intensive care unit; LOS, l
Evaluation.
448 The Journal of Thoracic and Cardiovascular SurgICU beds is all too often the rate-limiting step in reaching
target numbers of cardiac surgical procedures. There are nu-
merous reasons for this problem. Many hospitals were built
in an age when cardiac surgical patients were younger and
healthier and created a ratio between ICU and general
beds lower than currently required. With the ascent of per-
cutaneous coronary intervention in the last 2 decades,
patients coming to cardiac surgery have become progres-
sively older and have greater comorbidity.10,11 Complex
surgical procedures are performed on patients at the
extremes of life or who have advanced, decompensated
congestive heart failure.12 Even if these patients comprise
a relatively small proportion of the cardiac surgical mix,
they consume an inordinate amount of ICU resources. For
example, in our study less than 10% of patients had a pro-
longed stay in the ICU, but they used nearly 50% of all ICU
bed days.
The institution of fast-track protocols has allowed us to
minimize the time cardiac surgical patients remain in the
ICU or, in some institutions, to bypass the ICU alto-
gether.13,14 However, there is a lack of reliable tools to
identify potential candidates for fast-track protocols before
surgical intervention. The most well-established risk
assessment score is the Parsonnet score,5 a 22-factor scale
developed in 1989 to stratify cardiac surgical procedures
into 5 levels of mortality risk. In 1992, Tuman and col-
leagues6 developed a 14-factor model to stratify the risk
of serious morbidity after cardiac surgery based on 11 vari-
ables. In 1995, Tu and associates7 presented a similar 14-
point risk index for mortality, ICU, and hospital LOS. It is
a simple risk index based on 6 variables, 3 related to the
type of operation and 1 related to ventricular function (but
not patient comorbidity), that are used to predict mortality
and ICU and hospital LOS. Finally, in 2001, a cardiac anes-
thesia risk evaluation (CARE) score was devised.8 Based on
‘‘controlled’’ or ‘‘uncontrolled’’ comorbidity, surgical com-
plexity, and urgency, it is used to assess the risk of postop-
erative morbidity and mortality.
We found that the SPA score is superior to these systems
in being able to preoperatively discriminate between the 2
groups of patients (ie, fast track and prolonged stay)
that have the largest effect on ICU resource use and
efficiency.ital charges for scoring system comparison
Hospital LOS Hospital charges
t P value R2 Coefficient P value R2
<.0001 0.197 0.320 <.0001 0.281
<.0001 0.093 0.024 <.0001 0.139
<.0001 0.203 0.290 <.0001 0.261
<.0001 0.117 0.111 <.0001 0.157
.566 0.030 0.011 .389 0.02
ength of stay; SPA, Surgical Procedure Assessment; CARE, Cardiac Anesthesia Risk
ery c August 2011
TABLE 5. The ability of the SPA score to identify 2 groups of fast-track patients compared with the PS, CARE, Tuman, and Tu scores
Part A: 0–24 h* SPA ¼ 1A PS<5 CARE ¼ 1 Tuman<2 Tu<2
Relative risk 1.97 (1.68–2.30) 1.84 (1.41–2.41) 2.5 (1.98–3.39) 2.03 (1.66–2.49) 2.09 (1.63–2.67)
Odds ratio 2.9 (2.26–3.79) 2.08 (1.50–2.88) 3.13 (2.25–4.34) 2.61 (1.98–3.45) 2.48 (1.82–3.38)
Sensitivity 0.46 (0.41–0.51) 0.44 (0.37–0.52) 0.53 (0.45–0.60) 0.47 (0.41–0.53) 0.47 (0.40–0.54)
Specificity 0.77 (0.74–0.80) 0.72 (0.69–0.745) 0.73 (0.71–0.76) 0.745 (0.72–0.77) 0.73 (0.70–0.76)
Positive predictive value 0.49 (0.44–0.55) 0.21 (0.18–0.267) 0.25 (0.21–30) 0.36 (0.31–0.41) 0.27 (0.22–0.31)
Negative predictive value 0.75 (0.71–0.78) 0.88 (0.86–0.90) 0.90 (0.88–0.92) 0.82 (0.79–0.85) 0.87 (0.85–0.89)
Pearson c2 test 69.1 49.7 20.1 34.5 47.3
Part B: 0–48 hy SPA ¼ 1A PS<5 CARE ¼ 1 Tuman<2 Tu<2
Relative risk 2.53 (2.05–3.11) 1.85 (1.37–2.52) 2.68 (1.90–3.78) 2.22 (1.73–2.84) 1.93 (1.45–2.58)
Odds ratio 3.71 (2.82–4.89) 2.05 (1.44–2.90) 3.09 (2.11–4.54) 2.74 (2.03–3.71) 2.18 (1.56–3.05)
Sensitivity 0.78 (0.73–0.82) 0.72 (0.65–0.79) 0.79 (0.72–0.85) 0.76 (0.70–0.80) 0.73 (0.66–0.79)
Specificity 0.51 (0.48–0.55) 0.44 (0.41–0.47) 0.45 (0.42–0.48) 0.47 (0.44–0.50) 0.45 (0.42–0.48)
Positive predictive value 0.44 (0.40–0.48) 0.18 (0.16–0.22) 0.20 (0.17–0.23) 0.30 (0.27–0.34) 0.21 (0.18–0.24)
Negative predictive value 0.83 (0.79–0.86) 0.90 (0.87–0.93) 0.93 (0.90–0.95) 0.86 (0.83–0.89) 0.89 (0.86–0.92)
Pearson c2 test 92.8 35.9 16.6 21.7 44.7
*The relative risks, odds ratios, sensitivities, specificities, positive and negative predictive values, and Pearson c2 test results of an SPA score of 1A to predict patients who require
0 to 24 hours in the intensive care unit compared with the other scoring systems are shown, with 95% confidence intervals in parentheses. yThe relative risks, odds ratios, sen-
sitivities, specificities, positive and negative predictive values, and Pearson c2 test results of an SPA score of 1A to predict patients who require 0 to 48 hours in the intensive care
unit compared with the other scoring systems are shown, with 95% confidence intervals shown in parentheses. SPA, Surgical Procedure Assessment; PS, Parsonnet; CARE, Car-
diac Anesthesia Risk Evaluation.
Wagener et al Perioperative ManagementAt Columbia University Medical Center, the SPA score
has been in routine daily use as an integral part of the pub-
lished cardiac operating room schedule for more than 7
years. The SPA score is assigned in the cardiac surgical of-
fice during the patient’s preoperative visit, and all members
of the care team are familiar with it, including cardiac sur-
geons, cardiac anesthesiologists, scheduling administrators,
triage coordinators, operating room and ICU nursing staff,
and the ICU medical team. The SPA score allows us to pre-TABLE 6. The ability of the SPA score to identify 2 groups of prolonged-s
Part A:>7 d* SPA 2B or 3 PS  15
Relative risk 3.58 (2.81–4.57) 1.88 (1.64–2.15)
Odds ratio 5.51 (4.08–7.43) 3.17 (2.49–4.02)
Sensitivity 0.80 (0.76–0.84) 0.68 (0.64–0.72)
Specificity 0.57 (0.54–0.61) 0.59 (0.56–0.64)
Positive predictive value 0.43 (0.39–0.47) 0.59 (0.55–0.63)
Negative predictive value 0.88 (0.85–0.91) 0.68 (0.64–0.72)
Pearson c2 test 139.8 84.6
Part B:>10 dy SPA 2B or 3 PS  15
Relative risk 3.02 (2.54–3.58) 1.66 (1.48–1.86)
Odds ratio 5.48 (4.16–7.24) 2.91 (2.23–3.79)
Sensitivity 0.53 (0.48–0.59) 0.385 (0.345–0.427)
Specificity 0.83 (0.80–0.85) 0.82 (0.79–0.85)
Positive predictive value 0.55 (0.49–0.60) 0.65 (0.599–0.70)
Negative predictive value 0.82 (0.79–0.84) 0.61 (0.57–0.64)
Pearson c2 test 159.2 147.6
*The relative risks, odds ratios, sensitivities, specificities, positive and negative predictive v
greater than 7 days of intensive care unit care compared with the other scoring systems are
sensitivities, specificities, positive and negative predictive values, and Pearson c2 test results
care unit care compared with the other scoring systems are shown, with 95% confidence
CARE, Cardiac Anesthesia Risk Evaluation.
The Journal of Thoracic and Cadict the effect of a given surgical schedule on the ICU on
any given day. For example, if 5 of 8 scheduled patients
have SPA scores of 1A, we can anticipate a strong likeli-
hood that those 5 ICU beds will again become available
within 24 hours. Conversely, if only 2 patients have SPA
scores of 1A, it forewarns us that proactive triage (eg,
assigning some patients to the surgical ICU) will be
required to accommodate all ICU patients in the cardiotho-
racic ICU the next day.tay patients compared with the PS, CARE, Tuman, and Tu scores
CARE  4 Tuman  6 Tu  6
2.42 (1.98–2.98) 2.73 (2.14–3.48) 2.65 (2.09–3.37)
3.44 (2.625–4.507) 3.61 (2.680–4.875) 3.52 (2.618–4.725)
0.73 (0.69–0.78) 0.76 (0.70–0.80) 0.75 (0.69–0.79)
0.55 (0.52–0.59) 0.54 (0.51–0.57) 0.54 (0.51–0.57)
0.41 (0.38–0.45) 0.33 (0.30–0.38) 0.34 (0.31–0.38)
0.83 (0.79–0.86) 0.88 (0.85–0.90) 0.87 (0.84–0.89)
92.9 74.5 76.0
CARE  4 Tuman  6 Tu  6
2.79 (2.37–3.28) 2.07 (1.71–2.52) 1.87 (1.53–2.27)
5.08 (3.87–6.68) 2.74 (2.07–3.623) 2.37 (1.79–3.13)
0.513 (0.46–0.57) 0.44 (0.38–0.49) 0.41 (0.36–0.47)
0.83 (0.80–0.84) 0.78 (0.75–0.80) 0.77 (0.74–0.79)
0.56 (0.51–0.62) 0.38 (0.33–0.44) 0.37 (0.32–0.42)
0.79 (0.77–0.82) 0.82 (0.79–0.84) 0.80 (0.77–0.83)
65.0 37.7 112.4
alues, and Pearson c2 test results of an SPA score of 2B or 3 to predict patients needing
shown, with 95% confidence intervals in parentheses. yThe relative risks, odds ratios,
of an SPA score of 2B or 3 to predict patients needing greater than 10 days of intensive
intervals shown in parentheses. SPA, Surgical Procedure Assessment; PS, Parsonnet;
rdiovascular Surgery c Volume 142, Number 2 449
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P
MThere are a number of limitations to this study in general
and the SPA score in particular. We did not include the
EuroSCORE15 in the array of systems we compared be-
cause it was not in use at our institution at the time of
this study, although, like the Parsonnet Score, it is a com-
plex scale that was designed to predict operative mortality
and not ICU LOS. The SPA score itself is simple in con-
cept and practice, but its value is quite dependent on the
consistency and accuracy with which it is applied. The sys-
tem works best when the cardiac surgeon takes responsibil-
ity for quality control of the assignment or surgical
complexity and comorbidity. Obviously no preoperative
scoring system takes into account complications that occur
during or after surgical intervention and that provide an
important effect on ultimate ICU LOS. In this sense a pre-
operative scoring assignment, such as the SPA score, is
only one step in what should be a multimodal approach
to ICU triage. For example, if the surgical scheduler can
ensure that a substantial number of cases each day are
scored as SPA 1A, with a predictably short ICU LOS,
this could moderate the effect of patients with high mor-
bidities undergoing complex operations who might occupy
ICU beds for a prolonged period. Scheduling more com-
plex cases with higher SPA scores toward the end of the
week maximizes the use of the ICU over the weekend to
facilitate bed availability for the next week.
In conclusion,we have demonstrated that preoperative as-
signment of the SPA score reliably helps predict ICU LOS
after cardiac surgery and is able to discriminate between
fast-track (ICU LOS<48 hours) and prolonged-stay (>7
days) patients. The SPA score also correlates with hospital
LOS, charges, and in-hospital mortality. In sum, we have
found that the SPA score is an excellent tool to achieve
a more even, rational, and efficient use of the ICU and im-
prove communication between all caregivers.450 The Journal of Thoracic and Cardiovascular SurgReferences
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